title: Loxiglumide, a CCK-A antagonist, in irritable bowel syndrome. A pilot multicenter clinical study.
authors.affiliation: Middlesbrough General Hospital, UK.
authors.forename: P A
authors.initials: PA
authors.lastname: Cann
authors.forename: L C
authors.initials: LC
authors.lastname: Rovati
authors.forename: H L
authors.initials: HL
authors.lastname: Smart
authors.forename: R C
authors.initials: RC
authors.lastname: Spiller
authors.forename: P J
authors.initials: PJ
authors.lastname: Whorwell
mesh_terms: D000284:Administration, Oral; D003109:Colonic Diseases, Functional / Q000188:drug therapy* / Q000503:physiopathology; D003967:Diarrhea / Q000209:etiology / Q000517:prevention & control; D004305:Dose-Response Relationship, Drug; D010865:Pilot Projects; D011377:Proglumide / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors*
chemical_list: D011949:Receptors, Cholecystokinin; C053737:loxiglumide; D011377:Proglumide